NCT02213289 2021-04-08
PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression
University of Chicago
Phase 2 Completed
Clinical Trials
5 trialsNCT02590263 2020-09-03
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma
AbbVie
Phase 1/2 Completed
NCT01255657 2017-11-21
A Study of ABT-806 in Subjects With Advanced Solid Tumor Types
AbbVie
Phase 1 Completed
NCT01406119 2017-01-27
An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
AbbVie
Phase 1 Completed
NCT01472003 2013-01-14
An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types
AbbVie
Phase 1 Completed